Insider Transactions in Q3 2023 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2023
|
Celia Lin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,490
-11.92%
|
$23,840
$16.65 P/Share
|
|
Aug 21
2023
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,210
-2.1%
|
$83,360
$16.66 P/Share
|
|
Aug 21
2023
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,490
-5.24%
|
$23,840
$16.66 P/Share
|
|
Jul 24
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Bona fide gift
|
Indirect |
1,620
+50.0%
|
-
|
|
Jul 24
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Indirect |
1,620
-7.99%
|
-
|
|
Jul 05
2023
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.43%
|
$30,000
$3.94 P/Share
|